[GIZA]

Сообщение от BMB

Guidelines for the Management of Patients With Atrial Fibrillation
[Ссылки доступны только зарегистрированным пользователям ]

“In patients undergoing cardioversion or radiofrequency ablation for AF, use of warfarin or a DOAC is reasonable. Therapy should be given at least 3 weeks prior and 4 weeks following any cardioversion procedure. For patients undergoing radiofrequency ablation, continued use of warfarin, temporary interruption of dabigatran (24 hours pre- and post-procedure), and temporary interruption of rivaroxaban (held on day of procedure) are all safe”.